Nasdaq

Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV

SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...
STAT

Cepheid is accused of overcharging and undersupplying its Covid-19 test to poor countries

As controversy rises over equal access to Covid-19 medical products, a manufacturer of rapid, point-of care tests is being urged to lower the price of its diagnostic and also increase sales to a World ...
The Victoria Advocate

Xpert® Mpox Receives Emergency Use Listing by World Health Organization

SUNNYVALE, Calif., Nov. 4, 2024 /PRNewswire/ -- Cepheid today announced that The World Health Organization (WHO) has listed Xpert Mpox under its Emergency Use Listing (EUL) procedure. The EUL process ...
Healio

FDA clears first ‘rapid diagnostic’ hepatitis C RNA test for point-of-care settings

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first ...
Yahoo Finance

Cepheid Announces World Health Organization Prequalification of the Xpert® MTB/XDR test

Cepheid has supported TB testing worldwide for over 15 years. Xpert MTB/RIF, released in 2009 in collaboration with the Foundation for Innovative New Diagnostics (FIND), was a first-of-its-kind ...
Nasdaq

Cepheid Announces World Health Organization Prequalification of Xpert HIV-1 Qualitative Test

SUNNYVALE, Calif., April 3, 2024 /PRNewswire/ -- Cepheid today announced that Xpert® HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification. Inclusion on the prequalification ...
Reuters

Cepheid announces termination of contract with the CDC and Prevention to develop rapid point of care test for avian influenza; financial guidance for 2007 remains unchanged

Co announces the termination of its contract with the Centers for Disease Control and Prevention for development of a rapid point-of-care diagnostic to detect influenza viruses A and B, and the H5N1 ...